- Home
- TTSH vs EDIT Comparison
TTSH vs EDIT Comparison
Compare TTSH & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTSH
- EDIT
- Stock Information
- Founded
- TTSH 1985
- EDIT 2013
- Country
- TTSH United States
- EDIT United States
- Employees
- TTSH N/A
- EDIT N/A
- Industry
- TTSH Blank Checks
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTSH Finance
- EDIT Health Care
- Exchange
- TTSH Nasdaq
- EDIT Nasdaq
- Market Cap
- TTSH 264.5M
- EDIT 269.8M
- IPO Year
- TTSH N/A
- EDIT 2016
- Fundamental
- Price
- TTSH $5.91
- EDIT $3.92
- Analyst Decision
- TTSH
- EDIT Buy
- Analyst Count
- TTSH 0
- EDIT 11
- Target Price
- TTSH N/A
- EDIT $4.56
- AVG Volume (30 Days)
- TTSH 37.0K
- EDIT 2.7M
- Earning Date
- TTSH 11-06-2025
- EDIT 11-03-2025
- Dividend Yield
- TTSH N/A
- EDIT N/A
- EPS Growth
- TTSH N/A
- EDIT N/A
- EPS
- TTSH N/A
- EDIT N/A
- Revenue
- TTSH $340,228,000.00
- EDIT $38,901,000.00
- Revenue This Year
- TTSH N/A
- EDIT N/A
- Revenue Next Year
- TTSH N/A
- EDIT N/A
- P/E Ratio
- TTSH N/A
- EDIT N/A
- Revenue Growth
- TTSH N/A
- EDIT N/A
- 52 Week Low
- TTSH $4.62
- EDIT $0.91
- 52 Week High
- TTSH $7.75
- EDIT $4.05
- Technical
- Relative Strength Index (RSI)
- TTSH 40.20
- EDIT 73.38
- Support Level
- TTSH $5.80
- EDIT $3.01
- Resistance Level
- TTSH $6.36
- EDIT $3.58
- Average True Range (ATR)
- TTSH 0.40
- EDIT 0.30
- MACD
- TTSH -0.07
- EDIT 0.10
- Stochastic Oscillator
- TTSH 11.26
- EDIT 91.42
About TTSH Tile Shop Holdings Inc.
Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.